Big Data in Drug Discovery Digging beyond the Internet of Things-Drug Discovery Alert

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This edition of Drug Discovery Alert depicts the current landscape and the new trends across Big Data analytics in drug discovery. It comments on how a great number of companies and research institutions are digging beyond the Internet of Things in pharmaceutical development. The alert comprehends Big Data related topics such as cloud genomics, global influence solutions, and biomedical intelligence, among others, toward precision medicine approaches. Strategic insights explaining the impact of Big Data in the pharmaceutical industry and the overall healthcare sector, are also included along with industry and academic interactions.

The Drug Discovery Alert reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: genomics, Big Data, biomedical intelligence, multiomics, digital biology, personalized therapy, Internet of Things

Table of Contents

Big Data in Drug Discovery Digging beyond the Internet of Things-Drug Discovery AlertTrend OverviewBig Data in Drug DiscoveryTechnology ProfilesCloud-enabled Genomics-centric Next-generation CompanyLeveraging Big Data for Comprehensive, Unbiased, Global Influence SolutionsBiomedical Intelligence Cloud to Accelerate Drug Discovery and Precision MedicineData4CureBiomedical Intelligence Cloud to Accelerate Drug Discovery and Precision MedicineIntegrating Omics Big Data and Digital Biology into a Multidimensional ApproachBig Data Management and Analysis to Address Societal ConcernsImproving Healthcare Performance Through Big Data ApplicationsPowering Cancer Care Through New Cloud-Based Software Using Genetic Information for Personalized Treatment Profiles Strategic InsightsStrategic PerspectivesAppendixIndustry Interactions




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Related Subscription

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.